Table 2 Cox regression analysis of OS in 30 patients with HCC in our clinical cohort
From: Identification of a prognostic cuproptosis-related signature in hepatocellular carcinoma
Univariate analysis | Multivariate analysis | |||||
|---|---|---|---|---|---|---|
HR | 95% CI | P-value | HR | 95% CI | P-value | |
Age | 1.01 | 0.97–1.06 | 0.598 | – | – | – |
Gender | 1.21 | 0.16–9.21 | 0.852 | – | – | – |
HBsAg | 0.75 | 0.24–2.32 | 0.614 | – | – | – |
Cirrhosis | 0.47 | 0.16–1.34 | 0.157 | – | – | – |
AFP | 1.59 | 0.59–4.26 | 0.361 | – | – | – |
Tumor Size | 2.49 | 0.56–11 | 0.228 | – | – | – |
Tumor Count | 2.21 | 1.14–4.28 | 0.019 | 1.25 | 0.61–2.55 | 0.5415 |
PVTT | 2.97 | 1.01–8.79 | 0.049 | 2.59 | 0.29–23.43 | 0.3965 |
Distant Metastases | 0.78 | 0.18–3.45 | 0.747 | – | – | – |
TNM Stage | 3.96 | 1.98–7.91 | 0 | 5.57 | 2.32–13.36 | 1.00E–04 |
BCLC Stage | 1.74 | 1.04–2.93 | 0.035 | 0.59 | 0.2–1.72 | 0.3314 |
Tumor Grade | 2.04 | 0.93–4.47 | 0.075 | – | – | – |
PDXK | 2.92 | 1.08–7.92 | 0.035 | 3.98 | 1.18–13.41 | 0.026 |